Fullwidth Featured
California’s counting on an IPO tax windfall. Several factors are complicating the equation
The IPOs of SpaceX, OpenAI and Anthropic could create a tax windfall for the state of California. But experts say the revenue impact may be blunted.
Trump bid to fire Fed’s Lisa Cook cost her more than $1M in legal, security costs: Filing
A financial disclosure from Federal Reserve Governor Lisa Cook details large legal and security expenses
Hollister partners with Target to tap into $89 billion back-to-college shopping market
Hollister’s partnership with Target comes as both companies look to capitalize on the lucrative back-to-college shopping market.
Trump hits back at critics as Iran peace deal fuels debate over U.S. concessions
The deal sees both sides commit to further talks to reach a final agreement over the next 60 days and includes a $300 billion plan for Iran’s reconstruction.
Roy Cooper’s North Carolina Senate race could help decide control of the next Congress
North Carolina’s 2026 Senate race pits Democrat Roy Cooper against Republican Michael Whatley in a swing state Democrats haven’t won since with Obama in 2008.
Obama Center launch brings Democratic political glitterati to Chicago ahead of crucial elections
Political elites, White House alums, donors and business leaders will converge on Chicago on Thursday to commemorate the launch of the Obama Presidential Center.
Hegseth warns NATO allies that some nations will ‘fail’ U.S. defense review
The U.S. defense secretary also said it was “shameful” that European allies refused to give U.S. forces access to bases to strike Iran.
Carvana’s new vehicle strategy turns dealership into ‘playground,’ test-drive center with sales all online
But don’t expect Carvana to sell you a vehicle at one of its seven Stellantis stores, marking a stark contrast from typical franchised dealers.
Defense contractors would be barred from buying back their stock in bill approved by Senate panel
A bill the Senate Armed Services Committee approved would prevent defense contractors from buying back their stock without Pentagon approval.
UniQure to seek FDA approval for Huntington’s disease gene therapy after previous clash with agency
The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data supporting its application.